CXXC5 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of CXXC-type zinc finger protein 5 (CXXC5), a regulatory protein involved in various cellular processes, particularly in the Wnt/β-catenin signaling pathway. CXXC5 contains a CXXC-type zinc finger domain that enables it to bind to DNA and regulate gene expression. This protein is known to act as a negative regulator of the Wnt signaling pathway by interacting with Dishevelled (DVL), a key component of the pathway, and subsequently inhibiting the activation of β-catenin. The Wnt/β-catenin pathway plays a crucial role in controlling cell proliferation, differentiation, and migration, making CXXC5 an important modulator of these processes. By inhibiting CXXC5, researchers can study the impacts on Wnt signaling and related cellular activities.
In research settings, CXXC5 inhibitors are valuable tools for exploring the regulatory mechanisms of the Wnt/β-catenin pathway and understanding how CXXC5 contributes to cellular homeostasis and development. By blocking CXXC5, scientists can investigate how the inhibition of this protein affects the activation and downstream effects of Wnt signaling, including changes in gene expression profiles, cell behavior, and tissue architecture. These inhibitors also provide insights into the role of CXXC5 in other signaling pathways and cellular contexts where it may act as a broader transcriptional regulator. Additionally, CXXC5 inhibitors enable researchers to study the interactions between CXXC5 and other proteins within the cell, shedding light on the complex networks that govern cellular function and the maintenance of cellular identity. Through the use of CXXC5 inhibitors, scientists gain a deeper understanding of the molecular mechanisms that regulate signaling pathways, gene expression, and the intricate balance of cellular processes that contribute to development and tissue maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits the Wnt/β-catenin pathway, potentially affecting CXXC5 by modulating its role in this signaling pathway. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Targets DNA damage response pathways, which may indirectly influence CXXC5's involvement in DNA repair mechanisms. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that can indirectly impact CXXC5's function in cell differentiation and other processes by altering chromatin structure and gene expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET inhibitor that can indirectly influence CXXC5 by altering chromatin dynamics and gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K/Akt inhibitor that may have an indirect effect on CXXC5 by targeting signaling pathways involved in cell survival and proliferation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
A TGF-β pathway inhibitor that might indirectly affect CXXC5 by modulating cellular processes like differentiation and proliferation. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $62.00 $87.00 | 4 | |
An Aurora kinase inhibitor that can indirectly impact CXXC5's function in cell cycle regulation and response to DNA damage. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
A PARP inhibitor that can indirectly affect CXXC5's role in DNA damage response. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
A JAK/STAT inhibitor that might indirectly influence CXXC5 by modulating cytokine signaling pathways. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A Notch signaling pathway inhibitor that may indirectly impact CXXC5, especially in cell differentiation and development. | ||||||